DK37388A - Steroid-5-alfa-reduktaseinhibitorer - Google Patents
Steroid-5-alfa-reduktaseinhibitorerInfo
- Publication number
- DK37388A DK37388A DK037388A DK37388A DK37388A DK 37388 A DK37388 A DK 37388A DK 037388 A DK037388 A DK 037388A DK 37388 A DK37388 A DK 37388A DK 37388 A DK37388 A DK 37388A
- Authority
- DK
- Denmark
- Prior art keywords
- alpha
- steroid
- reductase inhibitors
- double bond
- reductase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/16—Benz[e]indenes; Hydrogenated benz[e]indenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/007,539 US4888336A (en) | 1987-01-28 | 1987-01-28 | Steroid 5-alpha-reductase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
DK37388D0 DK37388D0 (da) | 1988-01-26 |
DK37388A true DK37388A (da) | 1988-07-29 |
Family
ID=21726780
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK037388D DK168525B1 (da) | 1987-01-28 | 1988-01-26 | 17-substituerede 4-aza-5-alfa-androsten-3-on-derivater samt farmaceutisk middel med indhold deraf |
DK037388A DK37388A (da) | 1987-01-28 | 1988-01-26 | Steroid-5-alfa-reduktaseinhibitorer |
DK196691A DK169438B1 (da) | 1987-01-28 | 1991-12-05 | Fremgangsmåde til fremstilling af 17 substituerede 4-aza-5alfa-androsten-3-on-derivater samt mellemprodukter til anvendelse ved fremgangsmåden |
DK073594A DK169840B1 (da) | 1987-01-28 | 1994-06-21 | Fremgangsmåde til fremstilling af 17-substituerede 4-aza-5,7-androstadien-3-on-derivater |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK037388D DK168525B1 (da) | 1987-01-28 | 1988-01-26 | 17-substituerede 4-aza-5-alfa-androsten-3-on-derivater samt farmaceutisk middel med indhold deraf |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK196691A DK169438B1 (da) | 1987-01-28 | 1991-12-05 | Fremgangsmåde til fremstilling af 17 substituerede 4-aza-5alfa-androsten-3-on-derivater samt mellemprodukter til anvendelse ved fremgangsmåden |
DK073594A DK169840B1 (da) | 1987-01-28 | 1994-06-21 | Fremgangsmåde til fremstilling af 17-substituerede 4-aza-5,7-androstadien-3-on-derivater |
Country Status (13)
Country | Link |
---|---|
US (1) | US4888336A (fr) |
EP (1) | EP0277002B1 (fr) |
JP (1) | JPS63192800A (fr) |
AT (1) | ATE77388T1 (fr) |
AU (1) | AU608560B2 (fr) |
CA (1) | CA1325006C (fr) |
DE (1) | DE3871965T2 (fr) |
DK (4) | DK168525B1 (fr) |
ES (1) | ES2042725T3 (fr) |
GR (1) | GR3005284T3 (fr) |
IE (1) | IE61594B1 (fr) |
PT (1) | PT86652B (fr) |
ZA (1) | ZA88549B (fr) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5138063A (en) * | 1984-02-27 | 1992-08-11 | Merck & Co., Inc. | 17β-methoxycarbonyl-4-aza-androsten-1-en-3-ones |
US5571817A (en) * | 1984-02-27 | 1996-11-05 | Merck & Co., Inc. | Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones] |
US4814324A (en) * | 1987-03-06 | 1989-03-21 | Merck & Co., Inc. | Sterol inhibitors of testosterone 5α-reductase |
US5372996A (en) * | 1989-03-10 | 1994-12-13 | Endorecherche, Inc. | Method of treatment of androgen-related diseases |
US5595985A (en) * | 1989-03-10 | 1997-01-21 | Endorecherche Inc. | Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
US5405978A (en) * | 1989-05-30 | 1995-04-11 | The Upjohn Company | Oxidative preparation of 3,5-secoandrost-5-one-3,17 β-dioic acid |
DK0943328T3 (da) * | 1989-07-07 | 2004-10-18 | Endorech Inc | Kombinationsterapi til profylakse og/eller behandling af godartet prostatahyperplasi |
ES2189784T3 (es) * | 1989-07-07 | 2003-07-16 | Endorech Inc | Procedimiento para el tratamiento de enfermedades relacionadas con adrogenos. |
DE69032648T2 (de) * | 1989-07-07 | 1999-04-08 | Endorecherche Inc., Ste-Foy, Quebec | Androgenderivate zur Hemming der Aktivität der Sexualsteroide |
US5162332A (en) * | 1990-06-20 | 1992-11-10 | Merck & Co., Inc. | Selected 17 β-polyaroyl-4-aza-5 α-androst-1-en-3-ones as steroidal reductase inhibitors |
US5151430A (en) * | 1990-06-20 | 1992-09-29 | Merck & Co., Inc. | Specific 17β-thiobenzoyl-4-aza-5α-androst-1-en-3-ones as antiandrogen agents |
US5061802A (en) * | 1990-06-20 | 1991-10-29 | Merck & Co. Inc. | 17β-aminobenzoyl-4-aza-5α-androst-1-en-3-ones as benign prostatic hypertrophy agents |
US5098908A (en) * | 1990-06-20 | 1992-03-24 | Merck & Co., Inc. | 17β-hydroxybenzoyl-4-aza-5α-androst-1-en-3-ones as testosterone reductase inhibitors |
US5091380A (en) * | 1990-06-28 | 1992-02-25 | Merck & Co., Inc. | N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors |
IL101243A (en) * | 1991-03-20 | 1999-12-22 | Merck & Co Inc | Pharmaceutical preparations for the treatment of benign prostatic hyperplasia containing steroid history |
US5250539A (en) * | 1991-08-21 | 1993-10-05 | Eli Lilly And Company | Hexahydrobenzo[f]quinolinones |
US5304562A (en) * | 1991-10-09 | 1994-04-19 | Ciba-Geigy Corporation | 17β-substituted Aza-androstane derivatives |
CA2084799C (fr) * | 1991-12-17 | 2003-01-28 | Glenn J. Gormley | Methode de prevention du carcinome prostatique a l'aide de 17 beta-n-monosubstitue-carbamyl-4-aza-5 alpha-androst-1 -en-3-ones |
EP0547687A1 (fr) * | 1991-12-18 | 1993-06-23 | Merck & Co. Inc. | 17-bêta-substitués adamantyle/norbornanyle-4-aza-5-alpha-androsta-1-en-3-ones et androsta-3-ones |
US5543406A (en) * | 1991-12-20 | 1996-08-06 | Glaxo Wellcome, Inc. | Inhibitors of 5-α-testosterone reductase |
DE69329856D1 (de) * | 1992-05-20 | 2001-02-15 | Merck & Co Inc | Ester derivate von 4-aza-steroiden |
US5237064A (en) * | 1992-05-20 | 1993-08-17 | Merck & Co., Inc. | Process for producing 7β-substituted-aza-5αandrostan-3-ones |
EP0646007B1 (fr) * | 1992-05-20 | 1997-08-13 | Merck & Co. Inc. | NOUVELLES 4-AZA-5$g(a)-ANDROSTAN-ONES SUBSTITUEES EN POSITION 17$g(b), SATUREES ET DELTA-17 ET DELTA-20 OLEFINIQUES ET SATUREES UTILISEES COMME INHIBITEURS DE 5$g(a)-REDUCTASE |
US5710275A (en) * | 1992-05-20 | 1998-01-20 | Merck & Co., Inc. | 7β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitors |
WO1993023039A1 (fr) * | 1992-05-20 | 1993-11-25 | Merck & Co., Inc. | 4-aza-5a-androstan ones substituees utilisees en tant qu'inhibitors de la 5a-reductase |
AU675225B2 (en) * | 1992-05-20 | 1997-01-30 | Merck & Co., Inc. | 17-amino substituted 4-azasteroid 5alpha-reductase inhibitors |
EP0641204B1 (fr) * | 1992-05-20 | 2000-08-16 | Merck & Co. Inc. | 17-ethers et thioethers de 4-aza-steroides |
CA2135167A1 (fr) * | 1992-05-20 | 1993-11-25 | Donald W. Graham | Nouveaux derives 17-ester, amide, et cetone de 3-oxo-4-azasteroides, utilises comme inhibiteurs de la 5a-reductase |
RU94046044A (ru) * | 1992-05-20 | 1996-10-10 | Мерк Энд Ко. | Новые 7 бета -замещенные 4-аза- 5 альфа -холестан-оны в качестве ингибиторов 5 альфа -редуктазы, фармацевтическая композиция на их основе, способ ее получения |
ATE195129T1 (de) * | 1992-05-20 | 2000-08-15 | Merck & Co Inc | 4-azasteroide als 5-alpha-reduktase |
WO1993023053A1 (fr) * | 1992-05-21 | 1993-11-25 | Endorecherche Inc. | INHIBITEURS D'ACTIVITE DE LA TESTOSTERONE 5α-REDUCTASE |
GB9210880D0 (en) * | 1992-05-21 | 1992-07-08 | Smithkline Beecham Corp | Compounds |
AU680818B2 (en) * | 1992-05-21 | 1997-08-14 | Endorecherche Inc. | Improved antiandrogens |
GB9213901D0 (en) * | 1992-06-30 | 1992-08-12 | Smithkline Beecham Corp | Compounds |
US5302589A (en) * | 1992-08-07 | 1994-04-12 | Glaxo, Inc. | Heterocyclic inhibitors of 5-α-testosterone reductase |
US5324734A (en) * | 1992-09-15 | 1994-06-28 | Merck & Co., Inc. | Oxidization metabolites of 5-α-23-methyl-4-aza-21-nor-chol-1-ene-3, 20-dione |
HU212459B (en) * | 1992-10-02 | 1996-06-28 | Richter Gedeon Vegyeszet | Process for producing new 17-beta-substituted 4-aza-androstane-derivatives and pharmaceutical compositions containing them |
US5278159A (en) * | 1992-10-06 | 1994-01-11 | Merck & Co., Inc. | Aryl ester derivatives of 3-oxo-4-aza-androstane 17-β-carboxylates as 5-α-reductase inhibitors |
US5359071A (en) * | 1993-03-12 | 1994-10-25 | Merck & Co., Inc. | 15-substituted 4-azasteroids |
AU6413594A (en) * | 1993-03-24 | 1994-10-11 | Merck & Co., Inc. | Substituted 3-phenanthridinone derivatives as 5alpha-reductase inhibitors |
JP3325026B2 (ja) * | 1993-06-28 | 2002-09-17 | メルク エンド カンパニー インコーポレーテッド | 4−アザ−プレグナン5α−レダクターゼアイソザイム1阻害剤 |
TW408127B (en) * | 1993-09-17 | 2000-10-11 | Glaxo Inc | Androstenones |
TW369521B (en) * | 1993-09-17 | 1999-09-11 | Smithkline Beecham Corp | Androstenone derivative |
US5817818A (en) * | 1994-09-16 | 1998-10-06 | Glaxo Wellcome Inc. | Androstenones |
US5541322A (en) * | 1994-10-14 | 1996-07-30 | Glaxo Wellcome Inc. | Synthesis of 6-azaandrostenones |
US5595996A (en) * | 1994-10-25 | 1997-01-21 | Merck & Co., Inc. | 7-substituted 4-aza cholanic acid derivatives and their use |
US6365597B1 (en) * | 1996-02-14 | 2002-04-02 | Aventis Pharmaceuticals Inc. | 4-aza steroids |
US5998427A (en) * | 1998-05-14 | 1999-12-07 | Glaxo Wellcome Inc. | Androstenones |
ATE473759T1 (de) | 1998-05-22 | 2010-07-15 | Univ Leland Stanford Junior | Bifunktionelle moleküle sowie darauf basierende therapien. |
CN103259027A (zh) | 2005-04-28 | 2013-08-21 | 普罗透斯数字保健公司 | 药物信息系统 |
JP2009508494A (ja) | 2005-09-16 | 2009-03-05 | ラプトール ファーマシューティカル インコーポレイテッド | Crを含むタンパク質に対して特異的な受容体−結合タンパク質(rap)変異体を含む組成物およびその使用 |
PT2398500T (pt) | 2009-02-20 | 2019-06-14 | 2 Bbb Medicines B V | Sistema de entrega de medicamentos à base de glutationas |
TWI556839B (zh) | 2009-05-06 | 2016-11-11 | 研究室護膚股份有限公司 | 包含活性劑-磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2897202A (en) * | 1956-03-19 | 1959-07-28 | Monsanto Chemicals | 3-keto-4-aza-delta5-steroids and method of preparing same |
KR830000085B1 (ko) * | 1978-04-13 | 1983-02-08 | 제임스 에프. 너우톤 | 5α-환원효소 억제제로서 유용한 4-아자-17-치환-5α-안드로스탄-3-온류의 제조방법 |
US4191759A (en) * | 1978-04-13 | 1980-03-04 | Merck & Co., Inc. | N-substituted-17β-carbamoylandrost-4-en-3-one 5α reductase inhibitors |
AU527030B2 (en) * | 1978-04-13 | 1983-02-10 | Merck & Co., Inc. | 4-aza-17-substituted-5a-androstan-3-ones |
US4377584A (en) * | 1978-04-13 | 1983-03-22 | Merck & Co., Inc. | 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors |
US4220775A (en) * | 1979-03-15 | 1980-09-02 | Merck & Co., Inc. | Preparation of 4-aza-17-substituted-5α-androstan-3-ones useful as 5α-reductase inhibitors |
US4317817A (en) * | 1979-08-27 | 1982-03-02 | Richardson-Merrell Inc. | Novel steroid 5α-reductase inhibitors |
US4760071A (en) * | 1984-02-27 | 1988-07-26 | Merck & Co., Inc. | 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors |
NZ211145A (en) * | 1984-02-27 | 1988-10-28 | Merck & Co Inc | 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions |
GB8505862D0 (en) * | 1985-03-07 | 1985-04-11 | Erba Farmitalia | Steroidic 5alpha-reductase inhibitors |
-
1987
- 1987-01-28 US US07/007,539 patent/US4888336A/en not_active Expired - Fee Related
-
1988
- 1988-01-26 DK DK037388D patent/DK168525B1/da not_active IP Right Cessation
- 1988-01-26 DK DK037388A patent/DK37388A/da not_active IP Right Cessation
- 1988-01-26 IE IE18988A patent/IE61594B1/en not_active IP Right Cessation
- 1988-01-27 DE DE8888300697T patent/DE3871965T2/de not_active Expired - Fee Related
- 1988-01-27 ZA ZA880549A patent/ZA88549B/xx unknown
- 1988-01-27 ES ES88300697T patent/ES2042725T3/es not_active Expired - Lifetime
- 1988-01-27 EP EP88300697A patent/EP0277002B1/fr not_active Expired - Lifetime
- 1988-01-27 JP JP63016790A patent/JPS63192800A/ja active Pending
- 1988-01-27 AU AU10778/88A patent/AU608560B2/en not_active Ceased
- 1988-01-27 CA CA000557453A patent/CA1325006C/fr not_active Expired - Fee Related
- 1988-01-27 AT AT88300697T patent/ATE77388T1/de not_active IP Right Cessation
- 1988-01-28 PT PT86652A patent/PT86652B/pt not_active IP Right Cessation
-
1991
- 1991-12-05 DK DK196691A patent/DK169438B1/da not_active IP Right Cessation
-
1992
- 1992-07-29 GR GR920401614T patent/GR3005284T3/el unknown
-
1994
- 1994-06-21 DK DK073594A patent/DK169840B1/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US4888336A (en) | 1989-12-19 |
PT86652B (pt) | 1992-02-28 |
DE3871965D1 (de) | 1992-07-23 |
IE61594B1 (en) | 1994-11-16 |
DK169438B1 (da) | 1994-10-31 |
IE880189L (en) | 1988-07-28 |
ATE77388T1 (de) | 1992-07-15 |
DK196691D0 (da) | 1991-12-05 |
PT86652A (pt) | 1988-02-01 |
EP0277002B1 (fr) | 1992-06-17 |
EP0277002A2 (fr) | 1988-08-03 |
DE3871965T2 (de) | 1993-01-14 |
EP0277002A3 (en) | 1988-10-26 |
AU1077888A (en) | 1988-08-04 |
GR3005284T3 (fr) | 1993-05-24 |
DK196691A (da) | 1991-12-05 |
AU608560B2 (en) | 1991-04-11 |
ZA88549B (en) | 1988-07-27 |
DK37388D0 (da) | 1988-01-26 |
CA1325006C (fr) | 1993-12-07 |
DK169840B1 (da) | 1995-03-13 |
DK73594A (da) | 1994-06-21 |
DK168525B1 (da) | 1994-04-11 |
JPS63192800A (ja) | 1988-08-10 |
ES2042725T3 (es) | 1993-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT86652A (pt) | Steroid 5-alpha-reductase inhibitors | |
GEP19981274B (en) | Urinary follicle stimulating hormone, pharmaceutical composition, component of pharmaceutical composition | |
ZA899671B (en) | Phosphinic acid substituted steroids as inhibitors of steroid 5-alpha-reductase | |
GR1001503B (el) | Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών. | |
MY103352A (en) | Piperazinyl-heterocyclic compounds | |
IL87885A (en) | Pharmaceutical compositions having antiprogestational and anti-estrogenic activities for the treatment of hormone- dependent tumors | |
MY103518A (en) | Steroid 5- -reductase inhibitors | |
EP0293751A3 (en) | Taurohyodeoxycholic acid for the therapy of calculosis of the biliary tract and of biliary dyspepsia | |
NZ239022A (en) | Piperidyl ethers and thioethers; preparatory processes and pharmaceutical compositions | |
ZA899670B (en) | Phosphonic acid substituted steroids as steroid 5-alpha-reductase inhibitors | |
DE3686022D1 (de) | Monosaccharide enthaltende zusammensetzung zum heilen von wunden. | |
ZA886097B (en) | Pharmaceutical composition for the treatment of psoriasis | |
SE8405588D0 (sv) | New compounds | |
NZ223293A (en) | Beta-alkyl melatonins and pharmaceutical compositions | |
EP0266993A3 (en) | Method and therapeutic compositions for the treatment of bleeding disorders | |
EP0378824A3 (en) | Use of omega-3-fatty acids as anticachexia agents | |
DK99987D0 (da) | Oestrogenpraeparater | |
EP0256805A3 (fr) | Compositions pharmaceutiques pour le traitement de maladies des systèmes vasculaires occlus | |
ES8504774A1 (es) | Procedimiento para preparar derivados de 2-piperacinil-quinazolina | |
CA1268468C (fr) | Analogues des prostaglandines avec groupement thiabicycloheptane substitue | |
NZ228023A (en) | 24(r)-scymnol; preparatory processes and pharmaceutical compositions | |
IL86731A (en) | Pharmaceutical compositions containing estradien-3-one derivatives and androst-2-ene-carbonitrile derivatives | |
JO1519B1 (en) | New compounds (new benzimidazole derivatives are effective as ulcers) | |
CS330884A2 (en) | Zpusob vyroby 2-alkythio-1-aminoalkyl-5-oxo-2-pyrrolin-3-karbonitrilu |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PBP | Patent lapsed |